Search research articles
Contact Us
Filters
Showing results (571-580 of 652) with videos related to
Page
of 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
Antonio Palumbo, Francesca Gay, Federica Cavallo, et al.
European Journal of Haematology
|
May 16, 2017
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis
Philippe Moreau, Meletios A Dimopoulos, Paul G Richardson, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
The Lancet. Oncology
|
February 15, 2014
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Antonio Palumbo, Sara Bringhen, Shaji K Kumar, et al.
The New England Journal of Medicine
|
October 6, 2016
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Albert Oriol, Hareth Nahi, et al.
Journal of Hematology
|
November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience
Ciprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Haematologica
|
January 15, 2026
Hepatic response criteria in light chain amyloidosis: a multicenter validation study
Eli Muchtar, Giovanni Palladini, Stefan Schonland, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Haematologica
|
August 8, 2015
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Meletios A Dimopoulos, Katja C Weisel, Kevin W Song, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Page
of 66
Search research articles
Search
Showing results (571-580 of 652) with videos related to
Sort By:
Page
of 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
Antonio Palumbo, Francesca Gay, Federica Cavallo, et al.
European Journal of Haematology
|
May 16, 2017
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis
Philippe Moreau, Meletios A Dimopoulos, Paul G Richardson, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
The Lancet. Oncology
|
February 15, 2014
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Antonio Palumbo, Sara Bringhen, Shaji K Kumar, et al.
The New England Journal of Medicine
|
October 6, 2016
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Albert Oriol, Hareth Nahi, et al.
Journal of Hematology
|
November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience
Ciprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Haematologica
|
January 15, 2026
Hepatic response criteria in light chain amyloidosis: a multicenter validation study
Eli Muchtar, Giovanni Palladini, Stefan Schonland, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Haematologica
|
August 8, 2015
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone
Meletios A Dimopoulos, Katja C Weisel, Kevin W Song, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Page
of 66